Melissa Kotterman
Private Equity Investor bij Berkeley Frontier Fund
Profiel
Melissa Kotterman is the founder of 4D Molecular Therapeutics, Inc. which was founded in 2013.
She held the title of Vice President-Discovery & Engineering from 2013 to 2021.
Dr. Kotterman is also the founder of Ignite Immunotherapy, Inc. Currently, she is a Venture Partner at Berkeley Frontier Fund.
Dr. Kotterman received an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of California, Berkeley in 2013.
Actieve functies van Melissa Kotterman
Bedrijven | Functie | Begin |
---|---|---|
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Private Equity Investor | - |
Eerdere bekende functies van Melissa Kotterman
Bedrijven | Functie | Einde |
---|---|---|
4D MOLECULAR THERAPEUTICS, INC. | Oprichter | 01-11-2021 |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Oprichter | - |
Opleiding van Melissa Kotterman
Carnegie Mellon University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |